NewAmsterdam Pharma (NAMS) Shares Outstanding (Diluted) (2021 - 2026)

NewAmsterdam Pharma (NAMS) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 52.24 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.51 Bn
4 NuCana 279.75 Bn 279.75 Bn - 10.00
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 256.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 680.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 64.41 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 198.10 Mn
10 NewAmsterdam Pharma 3.72 Bn 3.72 Bn - 121.72 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 121.72 Mn
Dec 31, 2025 118.42 Mn
Sep 30, 2025 119.00 Mn
Jun 30, 2025 118.56 Mn
Mar 31, 2025 116.12 Mn
Dec 31, 2024 94.36 Mn
Sep 30, 2024 94.75 Mn
Jun 30, 2024 94.71 Mn
Mar 31, 2024 88.38 Mn
Dec 31, 2023 82.16 Mn
Sep 30, 2023 82.47 Mn
Jun 30, 2023 82.06 Mn
Mar 31, 2023 81.63 Mn
Dec 31, 2022 18.97 Mn
Dec 31, 2021 11.33 Mn